Serum ADMA, endothelial dysfunction, and atherosclerosis in hypervolemic hemodialysis patients
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.48, no.5, pp.1041-1047, 2018 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 48 Issue: 5
- Publication Date: 2018
- Doi Number: 10.3906/sag-1804-98
- Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
- Page Numbers: pp.1041-1047
- Keywords: Asymmetric dimethyl arginine, atherosclerosis, endothelial dysfunction, hemodialysis, hypervolemia, ASYMMETRIC DIMETHYLARGININE ADMA, LEFT-VENTRICULAR HYPERTROPHY, INTIMA-MEDIA THICKNESS, CHRONIC KIDNEY-DISEASE, STAGE RENAL-DISEASE, CARDIAC-HYPERTROPHY, MORTALITY, RISK, ULTRAFILTRATION, DIAMETER
- Eskisehir Osmangazi University Affiliated: Yes
Abstract
Background/aim: Asymmetric dimethyl arginine (ADMA) is a strong predictor of cardiovascular disease and mortality in patients under hemodialysis treatment. We aimed to investigate the relationship among volume status, endothelial dysfunction, and ADMA in hemodialysis patients.